Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutanous coronary revascularization - Topol,E-J.; Moliterno,D-J.; Herrmann,H-C. (N Engl J Med, 2001)